In a prespecified time-to-benefit secondary analysis presented at the European Congress on Obesity in 2025 and subsequently published, semaglutide produced a nominally significant reduction in MACE within the first 3 months (HR 0.63, 95% CI 0.410.95) and the first 6 months (HR 0.60, 95% CI 0.440.81), with curve separation visible within approximately 3 weeks of randomization [25], [26]
Always review your full medical history with your provider
When a patient receives a compounded semaglutide, they must extract a specific dose from a bottle on their own rather than inject a pre-dosed amount available in Ozempic or Wegovy
If you do all those other things, youll lose 15% of your body weight, WITHOUT the GLP-1
For practical context: a 220 pound Canadian starting both medications would expect to lose roughly 10 pounds on Orlistat versus 53 pounds on Retatrutide over similar timeframes
It causes the blood vessels to secrete substances that are pro-inflammatory and encourage clots
